Explore the Optimal Surgical Timing for Lung Surgery and Mediastinal Surgery After COVID-19 Infection
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Peng Zhang
Shanghai Pulmonary Hospital, Shanghai, China
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
6 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Anhui Chest Hospital
Shanghai, China
- Anqing Municipal Hospital
Shanghai, China
- Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
Shanghai, China
- Shanghai Pulmonary Hospital
Shanghai, China
- the First Affiliated Hospital of Anhui Medical University
Shanghai, China
- Wuhan University Renmin Hospital
Shanghai, China
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 29 Jan 2023
- Primary completion
- 30 Jun 2023
- Completion
- 30 Jun 2023
- Last update posted
- 18 Jul 2023
- Registered enrollment
- 2,000
- Registry id
- NCT05827328
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.